Clinical Trials Browser

Phase 1/2 × OTHER × Drug-Related Side Effects and Adverse Reactions × Clear all

NCT06789601 2025-06-19

Evaluating Informatics-assisted Immune-related Adverse Event Detection to Improve Registration Onto a Biorepository

Phase 1/2 Recruiting

Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT03638375 2023-12-12

ACTME

Phase 1/2 Unknown

Melanoma, Drug-Related Side Effects and Adverse Reactions

NCT04138381 2023-03-27

SeliGIST

Phase 1/2 Unknown

Neoplasm Metastasis, Sarcoma, Drug-Related Side Effects and Adverse Reactions

NCT00397501 2017-04-21

BBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the Brain

Phase 1/2 Withdrawn

Brain Neoplasms, Breast Neoplasms, Central Nervous System Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT00006012 2016-07-06

Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

Phase 1/2 Completed

Lung Neoplasms, Radiation Injuries, Drug-Related Side Effects and Adverse Reactions

NCT00028964 2011-02-23

Combination Chemotherapy After Surgery With or Without Chinese Herbal Therapy to Treat Symptoms in Women With Breast Cancer

Phase 1/2 Completed

Breast Neoplasms, Drug-Related Side Effects and Adverse Reactions